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Calcium signaling controls multiple cellular functions
and is regulated by the release from internal stores
and entry from extracellular fluid. In bone, osteoclast
differentiation is induced by RANKL (receptor activa-
tor of NF-kB ligand)-evoked intracellular Ca2+ oscilla-
tions, which trigger nuclear factor-activated T cells
(NFAT) c1-responsive gene transcription. However,
the Ca2+ channels involved remain largely unidenti-
fied. Here we show that genetic ablation in mice of
Trpv4, a Ca2+-permeable channel of the transient re-
ceptor potential (TRP) family, increases bone mass
by impairing bone resorption. TRPV4mediates baso-
lateral Ca2+ influx specifically in large osteoclasts
when Ca2+ oscillations decline. TRPV4-mediated
Ca2+ influx hereby secures intracellular Ca2+ concen-
trations, ensures NFATc1-regulated gene transcrip-
tion, and regulates the terminal differentiation and
activity of osteoclasts. In conclusion, our data indi-
cate that Ca2+ oscillations and TRPV4-mediated
Ca2+ influx are sequentially required to sustain
NFATc1-dependent gene expression throughout
osteoclast differentiation, and we propose TRPV4
as a therapeutic target for bone diseases.
INTRODUCTION
The intracellular Ca2+ concentrations ([Ca2+]i) in bone cells as
well as the external Ca2+ balance are crucial for bone homeosta-
sis. The external Ca2+ balance is regulated by transcellular
transport in intestine and kidney, which is critically dependent
on apical Ca2+ entry via TRPV5 and TRPV6, two highly Ca2+-
selective members of the superfamily of transient receptor
potential (TRP) cation channels (Van Cromphaut et al., 2001;
Hoenderop et al., 2005). Accordingly, genetic ablation of Trpv5
resulted in hypercalciuria, compensatory intestinal Ca2+ hyper-
absorption and decreased trabecular and cortical thickness of
long bones (Hoenderop et al., 2003). Remarkably, osteoclastCellactivity was impaired in TRPV5-deficient mice despite normal
osteoclastogenesis (van der Eerden et al., 2005). Besides this
external Ca2+ balance, recent studies have highlighted the
importance of intracellular Ca2+ signaling for osteoclast differen-
tiation (Takayanagi et al., 2002). Notably, receptor activator of
NF-kB ligand (RANKL) signaling evokes Ca2+ oscillations result-
ing in Ca2+/calcineurin-dependent dephosphorylation and acti-
vation of nuclear factor-activated T cells c1 (NFATc1), which
translocates to the nucleus and induces osteoclast-specific
gene transcription allowing differentiation of osteoclasts
(Takayanagi et al., 2002). Ca2+ oscillations are considered to
result from repetitive release of Ca2+ from the endoplasmic retic-
ulum; yet, in most cells, intracellular Ca2+ release occurs in con-
cert with Ca2+ entry via plasma membrane Ca2+-permeable
channels (Berridge et al., 2003). However, the plasmamembrane
Ca2+ channels characterized in osteoclasts aremainly involved in
transporting extracellular Ca2+ released during bone resorption
in a transcytosis-like process and include among others volt-
age-gated Ca2+ channels (Miyauchi et al., 1990), the receptor-
linked Ca2+ channel (Bennett et al., 2001), the ryanodine
receptor Ca2+ channel (Moonga et al., 2002), TRPV5 (vander Eer-
den et al., 2005), and theNa+/Ca2+ exchangers (Li et al., 2007). As
expected, many of these Ca2+ channels are localized at the api-
cal side of resorbing osteoclasts. Moreover, the locally increased
extracellular Ca2+ often induces osteoclast retraction and even
apoptosis. At the other hand, Ca2+-permeable channels involved
in controlling Ca2+ signaling during osteoclast differentiation are
still elusive.We therefore investigated the role of TRPV4, awidely
expressed Ca2+-permeable cation channel that can be activated
by diverse physical and chemical stimuli including cell swelling,
heat, mechanical stress, and phorbol esters such as 4a-phorbol
12, 13-didecanoate (4a-PDD) (Nilius et al., 2004).
We report that inactivation of TRPV4 in mice results in in-
creased trabecular bone volume due to reduced osteoclast
number and activity. Mechanistically, the basolaterally localized
TRPV4 channel mediates Ca2+ influx during maturation of oste-
oclasts, the stage when Ca2+ oscillations disappear. TRPV4
hereby maintains basal [Ca2+]i, which regulates NFATc1 activity
and induces differentiation and resorptive activity of osteoclasts.
In summary, this study shows that TRPV4 contributes to normal
bone remodeling by regulating Ca2+ influx and hereby intracellu-
lar Ca2+ signaling, which is required for osteoclast maturation.Metabolism 8, 257–265, September 3, 2008 ª2008 Elsevier Inc. 257
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Calcium Influx by TRPV4 Affects OsteoclastogenesisFigure 1. TRPV4 Inactivation Results in Increased Bone Volume in 12-Week-Old Mice Due to Reduced Bone Resorption
(A) Trabecular bone mineral density (BMD) measured in femora by pQCT (n = 8).
(B) Von Kossa staining on tibia sections. Scale bar represents 200 mm.
(C) Trabecular bone volume (BV/TV) on Von Kossa-stained sections (n = 8).
(D) Osteoblast number per bone surface (Ob.N/BS) on hematoxyline and eosin-stained tibia sections (n = 6).
(E) TRAP staining on proximal tibiae. Scale bar represents 100 mm.
(F) Osteoclast surface per bone surface (Oc.S/BS) on TRAP-stained sections (n = 8).
(G) Total osteoclast number per bone surface (Oc.N/BS; n = 6).
(H) Calcr mRNA levels in femora, expressed relative to WT mice set at 100% (n = 8).
(I) Serum CTX levels (n = 8). All quantitative data are means + SEM *p < 0.05, **p < 0.01, ***p < 0.001.RESULTS AND DISCUSSION
Bone Mass Is Increased in Trpv4/ Mice
To investigate whether TRPV4 is important for bone homeosta-
sis, we first examined the expression of Trpv4 in cultured osteo-
blasts and osteoclasts derived from bone marrow (BM) stromal
or hematopoietic cells respectively (see Figure S1A available
online). Both cell types expressed Trpv4, consistent with its
reported presence in a broad range of tissues (Liedtke et al.,
2000). Bone development was, however, not manifestly altered
by TRPV4 deficiency as growth curves and longitudinal bone
growth were normal in 2- and 12-week-old mice (Figure S1B).
Next, bone mass was analyzed in adult (12-week-old) mice by
peripheral quantitative computed tomography (pQCT) of the fe-
mur. Trabecular bone mineral density (Figure 1A) and cortical
thickness (Figure S1C) were significantly increased in TRPV4-
deficient mice (Trpv4/). Histological analysis of Von Kossa-
stained tibia sections (Figure 1B) confirmed these findings and
quantification showed that trabecular bone volume (BV/TV)
was increased by 67% in Trpv4/ mice compared to WT mice
(Figure 1C). This increase in bone mass was only detected after
weaning, as BV/TV was not different between genotypes at the
age of 2 weeks (data not shown). We found no significant differ-
ences in serum calcium or parathyroid hormone (PTH) levels258 Cell Metabolism 8, 257–265, September 3, 2008 ª2008 Elsevierbetween genotypes suggesting nomajor changes in the external
Ca2+ balance (Figures S1H and S1I). These data indicate that
the increased bone mass in adult Trpv4/ mice likely reflects
alterations in bone remodeling, a balanced process between
formation and resorption.
Trpv4/ Mice Show Reduced Bone Resorption
To elucidate the cellular mechanism underlying the increased
bone mass in adult Trpv4/ mice, we first investigated bone
formation parameters. Quantification of osteoblast number
(Figure 1D), osteoblast surface, mineral apposition rate and
bone formation rate (Figures S1D–S1F) was comparable be-
tween the genotypes, suggesting that osteoblast characteristics
are not manifestly changed by TRPV4 inactivation. In addition,
serum levels of osteocalcin, a bone formation-related parameter,
were unchanged in Trpv4/ mice compared to WT mice
(Figure S1G) as were mRNA levels of the osteoblast marker
runt-related transcription factor 2 (Runx2) analyzed in femurs
by quantitative real-time PCR (qRT-PCR) (Figure S1J). Finally,
in vitro osteogenic differentiation of isolated BM stromal
cells was not different between genotypes, as comparable
numbers and sizes of colonies staining positive for alkaline
phosphatase (Figure S1K) or alizarin red were obtained (data
not shown). These in vivo and in vitro data indicate that TRPV4Inc.
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Calcium Influx by TRPV4 Affects OsteoclastogenesisFigure 2. TRPV4 Is Crucial for the Terminal Differentiation and Resorptive Activity of Osteoclasts
(A) Western blot analysis of TRPV4 expression in cultured osteoclasts. HEK293 cells, transfected with murine Trpv4, are used as positive control, and b-actin is
used as loading control.
(B) TRAP staining of in vitro differentiated BM-derived hematopoietic cultures. Scale bar represents 50 mm.
(C) Number of TRAP-positive cells per well categorized by the number of nuclei per cell (n = 6).
(D) Nfatc1 mRNA level in cultured osteoclasts, expressed relative to WT mice set at 100% (n = 6).
(E) Pit-forming activity of osteoclasts cultured on dentine slices. Scale bar represents 50 mm.
(F) Resorbed area per dentine surface (n = 12).
(G) Confocal laser scanning of TRPV4 immunostaining (green) on WT osteoclasts cultured on osteologic discs. Nuclei were stained with Topro-3 (blue). Cross-
sectional (left) and reconstructed image in z-axis (right) is shown. Scale bar represents 50 mm.
(H) mRNA levels of Pacsin3 and Calcr during WT osteoclast differentiation (at the start and after 2 and 4 days of RANKL treatment). Pacsin3 mRNA levels are
shown relative to day 0, set as 1 (n = 4). All quantitative data are means + SEM *p < 0.05, ***p < 0.001.is expressed by osteoblastic lineage cells but also reveal that this
Ca2+-permeable channel is not crucial for the proliferation or dif-
ferentiation of osteoblasts.
The increased bone mass in adult Trpv4/ mice could not be
explained by altered bone formation, suggesting that bone re-
sorptionmaybe impaired. Indeed, lessosteoclastsweredetected
on tartrate-resistant acid phosphatase (TRAP)-stained tibia sec-
tions of adult Trpv4/ mice compared to WT mice (Figure 1E).
Quantification revealed a decrease of 35% in osteoclast surface
and 43% in total osteoclast number in Trpv4/ mice (Figures
1F and1G). These findingswere consistentwith amajor reduction
in calcitonin receptor (Calcr) mRNA levels, a marker of osteoclast
differentiation, analyzed on femora by qRT-PCR (Figure 1H). In
addition, serum collagen type I cross-linked C-telopeptide
(CTX) levels, reflecting osteoclast activity, were significantly de-
creased in Trpv4/ mice compared to WT mice (Figure 1I).
Osteoclastogenesis is regulated by the ratio between RANKL
andosteoprotegerin (OPG), two factorsproducedbyosteoblasts.
However, no difference in the ratio of RANKL to OPG mRNA
expression was observed between genotypes, suggesting anCell Mosteoclast-specific defect (Figure S1L). These data indicate that
trabecular bone resorption is decreased in Trpv4/mice, which
explains the observed increase in bone volume.
TRPV4 Mediates Terminal Osteoclast Differentiation
To explore the role of TRPV4 in bone resorption, we cultured os-
teoclasts starting from BM hematopoietic cells treated with
RANKL and macrophage colony-stimulating factor (M-CSF). As
expected, western blotting showed that TRPV4 was only detect-
able in the plasma membrane fraction of WT osteoclasts and
could not be detected in TRPV4-deficient cells (Figure 2A).
Next, the involvement of TRPV4 in osteoclast formation was an-
alyzed by quantifying both the number and multinuclearity of os-
teoclasts identified by TRAP staining (Figure 2B). No significant
differences were observed in the number of smaller osteoclasts
(<10 nuclei/cell) formed in Trpv4/- or WT-derived cultures
(Figure 2C). In contrast, the number of osteoclasts containing
more than 10 nuclei was significantly decreased when TRPV4
was lacking (Figure 2C). Interestingly, mRNA levels of the essen-
tial transcription factor Nfatc1 were significantly reduced inetabolism 8, 257–265, September 3, 2008 ª2008 Elsevier Inc. 259
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Calcium Influx by TRPV4 Affects OsteoclastogenesisTRPV4-deficient osteoclast cultures (Figure 2D). In addition,
bone resorption activity, assessed by quantifying resorption pit
formation on dentine slices (Figure 2E) or apatite-coated culture
discs (Figure S2A), was decreased by 40% in TRPV4-deficient
osteoclast cultures (Figures 2F and S2B). Of note, TRPV4-defi-
cient TRAP-positive cells on dentine slices were clearly smaller
compared to WT cells (Figure S2C), whereas the number of os-
teoclasts was comparable between genotypes (181 ± 22 versus
155 ± 15; WT versus Trpv4/, mean 6 SEM NS, n = 4). These
data indicate that TRPV4 is required for the terminal differentia-
tion and corresponding resorptive activity of osteoclasts, hereby
providing an explanation for the increased bone mass in TRPV4-
deficient mice. The osteopetrosis observed in Trpv4/ mice is
rather mild but is comparable to the moderately increased
bone mass caused by defective fusion (Yagi et al., 2005) or im-
paired terminal differentiation of osteoclasts (Sato et al., 2006).
In agreement with these studies, TRPV4-deficient osteoclasts
can still resorb bone tissue although their efficiency is signifi-
cantly impaired.
To understand the time-related function of TRPV4 in osteo-
clastogenesis, we first quantified TRPV4 expression at several
time points during osteoclast differentiation. Trpv4mRNA levels
increased markedly during the formation of small and medium
osteoclasts (day 3) and remained constant thereafter (Fig-
ure S2D). Moreover, TRPV4 protein expression was hardly de-
tectable during the early phases of differentiation; yet, it was
clearly induced at later stageswhen large osteoclasts are formed
(4 days of culture; Figure S2E). In a second step, we investigated
whether TRPV4 showed a specific subcellular localization pat-
tern that can be informative for its role. Typically, mature osteo-
clasts become polarized when attached to the bone surface,
with the apical surface specially organized for resorptive activi-
ties. Confocal microscopy of WT osteoclasts cultured on apa-
tite-coated culture disc showed that TRPV4 immunofluores-
cence was hardly detectable at the plasma membrane of small
osteoclasts (data not shown), but was clearly visible in mature,
active resorbing osteoclasts (Figure 2G). Reconstructing the
image in the z-axis revealed that TRPV4 protein specifically
localized to the basolateral membrane of mature osteoclasts
(Figure 2G). No TRPV4 signals were detected in the Trpv4/ os-
teoclasts (data not shown). The basolateral localization of TRPV4
indicates that this Ca2+ channel probably does not mediate
transcellular Ca2+ transport during bone resorption, as has
been proposed for TRPV5, which is localized at the ruffled border
of osteoclasts. Finally, we analyzed whether the expression ofCell MPACSIN3was altered during osteoclast differentiation. PACSIN3
has been reported to bind to TRPV4 in other cell types and
enhance the localization of TRPV4 to the plasma membrane
(Cuajungco et al., 2006). We found that Pacsin3 mRNA expres-
sion increased proportionally with osteoclast differentiation, in
parallel with the increase in Calcr expression (Figure 2H). This
finding may explain the prominent membrane localization of
TRPV4 in mature osteoclasts.
Taken together, the time-dependent increase in TRPV4
expression and its restricted localization at the basolateral mem-
brane suggests that TRPV4may regulate Ca2+ influx especially in
large osteoclasts and hereby contributes to Ca2+ signaling at
these later stages of osteoclast differentiation.
TRPV4 Activates NFATc1 Signaling in Osteoclasts
Ca2+ signaling during osteoclast differentiation is induced by
binding of the osteoclastogenic factor RANKL to its receptor
RANK, which leads to persistent activation of NFATc1 (Takaya-
nagi et al., 2002). Two Ca2+-dependent signaling pathways
working in concert have been characterized: first, the Ca2+/
calmodulin pathway inducing c-fos expression, which after bind-
ing to c-jun increases Nfatc1 transcription; and second, the
Ca2+-dependent activation of calcineurin, which leads to de-
phosphorylation of NFATc1 thereby allowing it to translocate to
the nucleus and induce osteoclast-specific gene expression
(Sato et al., 2006; Takayanagi et al., 2002).
To investigate the involvement of TRPV4 in these Ca2+-signal-
ing pathways, we treated mature osteoclasts (formed by M-CSF
and RANKL treatment for 5 days) with the specific TRPV4
agonist 4a-PDD for 3 hr in the absence of RANKL and analyzed
its effect on gene expression. Despite this short incubation pe-
riod, c-fos and c-jun mRNA levels were significantly increased
by 4a-PDD in WT osteoclasts, while they remained unchanged
in Trpv4/ osteoclasts (Figures 3A and 3B). In addition, a clear
induction in Nfatc1 mRNA expression was noted specifically in
WT osteoclasts (Figure 3C), which was accompanied by in-
creasedmRNA levels of theCalcr (Figure 3D), an established tar-
get gene of NFATc1 in osteoclasts (Asagiri et al., 2005). These
data are consistent with the decreased Nfatc1 and Calcr gene
expression observed in TRPV4-deficient cultures and bones, re-
spectively (Figures 2D and 1H). Next, we analyzed the effect of
ligand-dependent TRPV4 stimulation on NFATc1 activation
and nuclear translocation. Continuous RANKL treatment in-
duced and maintained nuclear translocation of NFATc1 in ma-
ture WT osteoclasts, whereas subsequent starvation for RANKLFigure 3. Activation of TRPV4 Regulates Ca2+ Signaling during Osteoclast Differentiation and Survival
(A–D) mRNA expression in osteoclasts cultured with M-CSF and RANKL for 5 days, starved for RANKL during 6 hr, and then treated with 4a-PDD or vehicle
(ethanol) for 3 hr. (A) c-fos (Fos), (B) c-jun (Jun), (C) Nfatc1, and (D) Calcr mRNA levels are expressed relative to vehicle set at 100% (n = 6).
(E) The nuclear staining of NFATc1 (green) in culturedmatureWT osteoclasts (RANKL + 6 days) is lost after RANKLwithdrawal (RANKL 1 day; upper panels), but
preserved by 4a-PDD (1 mM) treatment (middle panels). The latter effect was blunted by 1 mg/ml cyclosporine pretreatment (lower panels). Nuclei were stained
with Topro-3 (blue). Scale bar represents 100 mm.
(F) TRAP staining on osteoclasts, switched at day 5 tomediumwithout RANKL and treatedwith 4a-PDD (100 nMor 1 mM) or vehicle for 24 hr. Scale bar represents
100 mm.
(G) Osteoclast number per well after RANKL withdrawal in the absence or presence of 4a-PDD for 24 hr (100 nM or 1 mM; *p < 0.05; n = 6).
(H) TUNEL-positive WT osteoclasts visualized by TRAP counterstaining after RANKL withdrawal. Scale bar represents 100 mm.
(I) Percentage of TUNEL-positive WT osteoclasts. Cells were cultured with or without RANKL and treated with 4a-PDD (0.2 mM or 2 mM) or RR (0.2 mM) for 24 hr.
*p < 0.05 (n = 6).
(J) Steady-state [Ca2+]i levels in large osteoclasts at 34
C in the presence or absence of RANKL and treated with 4a-PDD (2 mM) for 8 or 18 hr. All quantitative data
are means + SEM *p < 0.05, **p < 0.01.etabolism 8, 257–265, September 3, 2008 ª2008 Elsevier Inc. 261
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Calcium Influx by TRPV4 Affects Osteoclastogenesisduring 24 hr relocalized NFATc1 to the cytoplasm (Figure 3E).
Remarkably, treatment with 4a-PDD rescued NFATc1 nuclear
translocation in the absence of RANKL in WT osteoclasts, and
this effect of 4a-PDD was blunted when calcineurin activity
was blocked using cyclosporine. These data indicate that
TRPV4 activation in mature osteoclasts enhances their terminal
differentiation mainly by inducing NFATc1 translocation.
Besides its vital role in osteoclast differentiation, Ca2+ influx
and Ca2+ signalingmight also influence osteoclast survival, anal-
ogous to the effect of Ca2+ signaling observed in other cell
types. Notably, stimulation of Ca2+ influx inhibited apoptosis
and induced survival of developing neurons deprived of nerve
growth factor (Koike et al., 1989). To test the contribution of
TRPV4 to osteoclast survival, cultures of mature osteoclasts
were deprived of RANKL and further cultured with or without
the TRPV4 agonist 4a-PDD. Removal of RANKL for 24 hr mani-
festly reduced the number of osteoclasts in both genotypes
(Figure 3F). Strikingly, treatment with 4a-PDD during RANKL
withdrawal preserved a significantly large number of osteoclasts
with normal morphology in WT cultures but not in Trpv4/ cul-
tures (Figures 3F and 3G). Analysis of DNA fragmentation by
TUNEL staining showed that osteoclastic cell death was due to
apoptosis (Figure 3H). RANKL-deprivation of WT osteoclasts
increased the number of TUNEL-positive osteoclasts, and addi-
tion of the TRPV4 inhibitor ruthenium red (RR) induced apoptosis
even more (Figure 3I). In addition, 4a-PDD treatment dose de-
pendently decreased the number of TUNEL-positive osteoclasts
induced by RANKL withdrawal or RR treatment. This prosurvival
effect of TRPV4 activation suggests that [Ca2+]i is altered during
osteoclast apoptosis. Indeed, [Ca2+]i measurements revealed
that basal [Ca2+]i was decreased 8 hr after RANKL withdrawal
which could be restored inWT osteoclasts by 4a-PDD treatment
(Figure 3J) but not in Trpv4/ osteoclasts (data not shown).
These findings are in agreement with previous studies showing
that decreased [Ca2+]i in osteoclasts is proapoptotic, although
the molecular players remained unidentified (Komarova et al.,
2003; Mentaverri et al., 2003). These present data indicate that
TRPV4 stimulates Ca2+-signaling pathways in mature osteo-
clasts, hereby mediating their terminal differentiation and en-
hancing survival of RANKL-deprived osteoclasts.
Ca2+ Oscillations and TRPV4-Mediated Ca2+ Influx Are
Sequentially Required
Previous studies have shown that RANKL-evoked Ca2+ signals
in osteoclasts are characterized by baseline Ca2+ oscillationsCell M(Yang and Li, 2007; Takayanagi et al., 2002). Indeed, spontane-
ous Ca2+ oscillations were readily detected in the majority of
small (S; less than 5 nuclei) osteoclasts from both WT and
TRPV4-deficient mice (Figures 4A–4C). Oscillations persisted
for several minutes in Ca2+-free extracellular solution, demon-
strating that the generation of the Ca2+ spikes is not critically de-
pendent on Ca2+ influx through plasma membrane channels
(Figure S3A). This indicates that the spontaneous Ca2+ oscilla-
tions originate from Ca2+ release from intracellular Ca2+ stores
followed by Ca2+ reuptake. On average, however, removal of ex-
tracellular Ca2+ led to a gradual decrease in both spike frequency
and amplitude (Figures S3B and S3C), implying that some Ca2+
influx is required to sustain the normal oscillatory pattern.
Remarkably, the occurrence of regular oscillations was signif-
icantly lower in medium-sized (M; 5–10 nuclei) osteoclasts (p =
0.037, S versus M), and oscillations were never observed in dif-
ferentiated large (L) osteoclasts containing more than 10 nuclei
(p < 0.001, S or M versus L) (Figures 4A–4C, S4A–S4C, and
Movies S1 and S2). However, we found no significant differences
between WT and TRPV4-deficient mice in the number of osteo-
clasts exhibiting oscillations at the different stages of differenti-
ation (Figure 4C), or in the frequency and amplitude of the spikes
(Figures 4D and 4E). These data demonstrate that TRPV4 is not
required for the generation of Ca2+ oscillations in osteoclasts. On
the other hand, the involvement of TRPV4 in the Ca2+/calci-
neurin-NFATc1 pathway (Figure 3E) and its basolateral localiza-
tion, specifically in differentiated osteoclasts (Figure 2G), sug-
gest that this channel may regulate Ca2+ influx at certain
stages of osteoclast differentiation. Indeed, stimulation of
TRPV4 with 4a-PDD at room temperature evoked robust in-
creases in [Ca2+]i in large osteoclasts obtained from WT mice,
which were fully abolished in TRPV4-deficient large osteoclasts
(Figure 4F). In contrast, the Ca2+-ionophore ionomycin evoked
equal responses in large osteoclasts derived from either geno-
type (data not shown). Moreover, since TRPV4 is activated by
moderate heat above 30C (Watanabe et al., 2002), we per-
formed [Ca2+]i measurements in large osteoclasts at 25
C and
34C. Importantly, at 34C the basal [Ca2+]i in Trpv4
/ osteo-
clasts was significantly lower than in WT osteoclasts (Figures
4F and 4G). These data indicate that TRPV4 is functional as
a Ca2+ influx channel in large mature osteoclasts, where it allows
basal Ca2+ influx at physiological temperatures. Interestingly, we
found a clear correlation between TRPV4 activity, as assessed
by the response to 4a-PDD, and the differentiation state of WT
osteoclasts: small osteoclasts, which generally displayed Ca2+Figure 4. TRPV4 Regulates Ca2+ Influx but Not Ca2+ Oscillations during Osteoclast Differentiation
(A and B) Representative [Ca2+]i recordings in small (<5 nuclei) and large (>10 nuclei) osteoclasts derived from WT (A) and Trpv4
/ mice (B).
(C) Percentage of oscillating cells in the categories of small (S), intermediate (M; 5–10 nuclei), and large (L) osteoclasts.
(D and E) Average frequency (D) and amplitude (E) of Ca2+ spikes in oscillating osteoclasts (WT, n = 26; Trpv4/, n = 25; means + SEM).
(F) Average responses to 4a-PDD (1 mM) in large osteoclasts derived fromWT (black lines) and in Trpv4/ (gray lines) mice, measured at 25C and 34C (n = 10,
solid lines represent mean; dotted lines represent SEM).
(G) Steady-state [Ca2+]i levels in large osteoclasts at 25
C and 34C (n = 10).
(H) Representative Ca2+ oscillations and responses to 4a-PDD (5 mM) in S, M, and L osteoclasts derived from WT mice. RR (2 mM) was added after 4a-PDD
treatment.
(I) Maximal induction by 5 mM 4a-PDD, expressed as percentage of steady-state value in S, M, and L osteoclasts derived from WT mice (n = 6, means + SEM)
*p < 0.05.
(J) Working model for maintenance of [Ca2+]i and Ca
2+ signaling during osteoclast differentiation. At the start, Ca2+ oscillations are persistently present and
dominantly regulate [Ca2+]i. When osteoclasts become larger, Ca
2+ oscillations diminish, and TRPV4-mediated Ca2+ influx becomes operational. This process
is required to sustain [Ca2+]i and NFATc1 activation during terminal differentiation of osteoclasts.etabolism 8, 257–265, September 3, 2008 ª2008 Elsevier Inc. 263
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large osteoclasts, which fully lack Ca2+ oscillations, showed
robust responses to 4a-PDD, and this response was blocked
by RR (Figure 4H). In medium-sized WT osteoclasts, both Ca2+
oscillations and 4a-PDD responses were observed; however,
the 4a-PDD response in these medium-sized cells was signifi-
cantly smaller than in large osteoclasts (Figure 4I). Taken to-
gether, the intracellular [Ca2+]i measurements indicate that
during differentiation of osteoclasts a gradual shift occurs from
spontaneousCa2+ oscillations to sustainedCa2+ influx via TRPV4.
Based on these data, we propose the following working
model (Figure 4J): RANKL stimulation evokes Ca2+ oscillations
originating from alternate Ca2+ release from and reloading into
intracellular stores, which induce NFATc1-dependent gene
transcription. This oscillatory behavior is gradually lost during
differentiation, and at these later stages, Ca2+ influx from the ex-
tracellular space via TRPV4 channels becomes necessary for
sustained Ca2+ signaling, NFATc1 activation, and terminal
differentiation of osteoclasts. The present study elucidates
a role for TRPV4 in bone remodeling and shows that Ca2+ signals
required for osteoclast differentiation are not only dependent on
intracellular Ca2+ release but also on extracellular Ca2+ influx
mediated by TRPV4. Outstanding questions remain. What are
the in vivo stimuli for TRPV4 activation in osteoclasts? How is
the communication between Ca2+ influx and intracellular Ca2+
release in osteoclasts? How is [Ca2+]i regulated in large multinu-
clear osteoclasts? However, since genetic ablation of TRPV4
impaired osteoclast activity without affecting osteoblast func-
tion, resulting in manifestly increased bone mass in adult mice,
pharmacological blockade of TRPV4 function may offer a potent
therapy for bone diseases caused by excessive bone resorption.
EXPERIMENTAL PROCEDURES
Animals
WT and Trpv4/mice (Suzuki et al., 2003) received normal diet (Carfil Quality-
Pavan Service). Experiments were approved by the ethical committee of the
KULeuven. Genotyping was performed by PCR on extracted genomic DNA,
and analyses were performed on 2- and 12-week-old male mice. Blood was
collected to analyze CTX by Ratlaps ELISA Kit (Nordic Bioscience Diagnos-
tics), and bones were dissected and processed for pQCT and histological
analysis as described in Masuyama et al. (2006) and Supplemental Data.
Primary BM Hematopoietic Cell Cultures and In Vitro Osteoclast
Resorption Assay
Hematopoietic cells were isolated and cultured in a-MEM containing 10%FCS
and 10 ng/ml M-CSF (R&D Systems). One day later, nonadhesive cells were
seeded at 115,000 cells/cm2 in medium containing RANKL (100 ng/ml, Pepro-
Tech) and M-CSF (20 ng/ml). After 5 days, cells were stained for TRAP, and
osteoclasts were counted as described (Daci et al., 1999). To evaluate the
effect of TRPV4 on osteoclast survival, mature osteoclasts were switched to
mediumwith or without RANKL, treatedwith 4a-PDD or RR, and analyzed after
TRAP and/or TUNEL staining using the Cell Death Detection Kit (Roche). All
quantifications were performed on 2 wells per condition, and repeated 2 to 4
times. To analyze osteoclast resorptive activity, BM hematopoetic cells were
cultured on dentine slices under conditions described above (12 wells per ge-
notype). Resorption pits were visualized byMayer’s Hematoxylin Solution after
removal of the cells, and the resorbed area was quantified as described (Daci
et al., 2000). TRPV4 protein expression in cultured osteoclasts was detected
by western blotting on plasma membrane extracts as described (Vriens
et al., 2005). Lysate from HEK293 cells transfected with murine TRPV4 was
used as positive control (Nilius et al., 2001).264 Cell Metabolism 8, 257–265, September 3, 2008 ª2008 ElsevierImmunostaining of TRPV4 and NFATc1 in Cultured Osteoclasts
Osteoclasts cultured on calcium-phosphate-coated discs (BD Biosciences)
for 5 days were fixed with 4% PF (w/v), permeabilized with 0.02% Triton X
and after blocking with 10% BSA, incubated with anti-TRPV4 antibodies
(1:500) (Vriens et al., 2005) followed by Alexa 488-labeled secondary anti-
bodies. Topro-3 (Invitrogen) was used for nuclear staining. For NFATc1 immu-
nostaining, osteoclasts were cultured for 5 days, then switched to medium
with or without RANKL and exposed to 1 mg/ml cyclosporine (Sandimmune,
Novartis) or vehicle for 3 hr, where after 1 mM 4a-PDD (Sigma) was added
for 21 hr. Immunostaining was performed according to the method described
by Takayanagi et al. (2002) using anti-NFATc1 antibodies (1:500; Santa Cruz
Biotechnology). Analysis was by confocal laser scanning (Radiance 2100,
Bio-Rad/Carl Zeiss, Inc.).
Intracellular Ca2+ Measurements
Osteoclasts were cultured with RANKL and M-CSF for 5 days before Ca2+
imaging. Osteoclasts were loaded with 2 mM Fura-2 acetoxymethyl ester to
perform Ca2+ measurement at 25C or 34C (Vriens et al., 2005). Ca2+ oscilla-
tions at 25C were monitored by Cell Imaging Software (Olympus) with extra-
cellular solution containing 150 mM NaCl, 6 mM KCl, 1 mM CaCl2, 1 mM
MgCl2, 10 mM HEPES, 10 mM D-glucose, pH 7.4; or Ca
2+-free solution con-
taining 1 mM EGTA instead of CaCl2. For each condition, at least 10 large
(>10 nuclei), 10 small (<5 nuclei), and 10 intermediate osteoclasts were as-
sayed in two independent experiments.
Isolation of RNA and Quantitative Real-Time PCR
Total RNA of femora and cultured cells was isolated, and cDNA was synthe-
sized as described (Masuyama et al., 2006).
qRT-PCR was performed on the 7500 Fast Real-Time PCR System (Applied
Biosystems), using specific forward and reverse oligonucleotide primers, and
probes and levels were normalized for hypoxanthine-guanine phosphoribosyl
transferase 1 (Hprt1) expression (Table S1). Nfatc1 and Pacsin3 mRNA ex-
pression was analyzed by TaqMan gene-expression assays (Nfatc1:ID
Mm00479445-m1, Pacsin3:ID Mm00499032-m1, Applied Biosystems).
Statistical Analysis
Quantified results are expressed as the mean ± standard error of the mean
(SEM). To assess the effect of genotype or treatment, data were compared
using Student’s t test or Mann-Whitney’s test after F test. For multiple compar-
ison, Fisher’s LSD was performed after ANOVA. Comparison of the number of
oscillating cells between genotypes or stages of differentiation was assessed
using the chi-square test or Fischer exact test. p < 0.05 was considered
significant.
SUPPLEMENTAL DATA
Supplemental Data include four figures, Supplemental Experimental Proce-
dures, Supplemental References, one table, and twomovies and can be found
online at http://www.cellmetabolism.org/cgi/content/full/8/3/257/DC1/.
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